In an HIV‑positive patient on bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy) with a normal white‑blood‑cell count but markedly elevated erythrocyte sedimentation rate and C‑reactive protein, what should be the next diagnostic step?

Urgent Workup for Occult Infection or Inflammatory Process

In an HIV-positive patient on Biktarvy with normal WBC but markedly elevated inflammatory markers (ESR 127, CRP 12.45), you must immediately investigate for active opportunistic infections, tuberculosis, malignancy, or immune reconstitution inflammatory syndrome (IRIS).

Immediate Diagnostic Steps

1. Assess HIV Control Status

• Check HIV viral load and CD4 count immediately 1
• If CD4 <200 cells/μL, heightened concern for opportunistic infections
• Confirm medication adherence to Biktarvy

2. Screen for Tuberculosis (Priority #1)

• Obtain chest X-ray
• Collect three sputum samples for acid-fast bacilli smear and culture 2
• Consider tuberculin skin test or interferon-gamma release assay
• TB is the most common cause of this inflammatory pattern in HIV patients, even with normal WBC 2

3. Evaluate for Other Opportunistic Infections

Based on CD4 count:

• If CD4 <200 cells/μL: Consider Pneumocystis jirovecii pneumonia (obtain induced sputum or bronchoscopy if respiratory symptoms) 3
• Blood cultures (2 sets): HIV patients have 100-fold higher risk of bacteremia, especially with Streptococcus pneumoniae 2
• Cryptococcal antigen (serum): If CD4 <100 cells/μL
• CMV PCR: If CD4 <50 cells/μL and systemic symptoms
• Hepatitis B and C serologies: Reactivation can cause elevated inflammatory markers 3

4. Screen for Malignancy

• Complete physical examination focusing on lymphadenopathy
• Consider CT chest/abdomen/pelvis if unexplained constitutional symptoms
• HIV patients have increased risk of lymphoma and other malignancies 1

5. Assess for Immune Reconstitution Inflammatory Syndrome (IRIS)

• Review timing: IRIS typically occurs within first 2-12 weeks of ART initiation 4
• If recently started Biktarvy, consider unmasking of subclinical infection (MAC, CMV, tuberculosis, cryptococcus) 4
• IRIS can present with elevated inflammatory markers despite viral suppression

6. Rule Out Biktarvy-Related Complications

While rare, consider:

• Lactic acidosis: Check lactate level, liver function tests 4, 5
• Renal function: Serum creatinine and eGFR (tenofovir alafenamide component can cause renal issues in predisposed patients) 4

Critical Laboratory Panel

Order immediately:

• HIV viral load and CD4 count
• Complete metabolic panel (creatinine, liver enzymes, lactate)
• Blood cultures × 2
• Serum cryptococcal antigen (if CD4 <200)
• Hepatitis B surface antigen, hepatitis C antibody
• Chest X-ray
• Sputum AFB × 3 (if any respiratory symptoms or abnormal CXR)

Common Pitfalls to Avoid

1. Do not dismiss normal WBC: HIV patients frequently have normal WBC despite serious infections 2, 6
2. ESR >100 mm/hr demands investigation: This degree of elevation suggests active infection, malignancy, or severe inflammatory process 6, 7
3. Do not assume viral suppression equals no complications: IRIS and opportunistic infections can occur despite effective ART 4
4. Consider drug-drug interactions: Review all medications and supplements that could interact with Biktarvy 1

Interpretation of Inflammatory Markers in HIV

• ESR is commonly elevated in HIV patients (mean ~85 mm/hr in symptomatic patients vs. 20 mm/hr in controls) 6
• However, ESR >100 mm/hr with CRP >10 mg/dL indicates active pathology requiring investigation 7, 8
• CRP responds more rapidly to acute processes; ESR reflects chronic inflammation 8, 9
• The combination of both being markedly elevated suggests an active, significant inflammatory process 10

Continue Biktarvy while investigating unless lactic acidosis or acute renal failure is identified 1. The regimen has a high barrier to resistance and should not be interrupted without clear indication 1.